Clinical Trials Browser

Phase 2 × Hematologic Diseases × Azacitidine × Clear all

NCT02494258 2026-04-02

A Study to Evaluate Long-term Safety of CC-486 (Oral Azacitidine) in Subjects With Hematological Disorders

Phase 2 Completed

5 enrolled 10 charts

Other hematologic neoplasm

Hematologic Diseases, Neoplasms, Hematologic Neoplasms

NCT04062266 2026-01-13

AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission

Phase 2 Active not recruiting

Other hematologic neoplasm

Hematologic Diseases, Leukemia, Myeloid, Acute